Opioid agonist treatments (OATs) such as methadone and buprenorphine-naloxone are standard therapy for opioid use disorder, but treatment duration is decreasing as fentanyl becomes more prevalent in ...

Patients who are prescribed higher daily doses of the medication buprenorphine for opioid use disorder are significantly more ...

Few patients with opioid toxicity receive opioid agonist therapy (OAT), data suggest. In a retrospective study that examined about 21,000 hospital visits related to opioid use disorder (OUD) in ...

Widespread access to opioid agonist treatment (OAT) can reduce the risk of suicide by 35% among people with opioid use disorder, according to a new study published in Addiction. Researchers led by the ...

TORONTO - A new study led by researchers at the University of Toronto's Leslie Dan Faculty of Pharmacy and Unity Health Toronto shows that almost one quarter of hospital-treated opioid toxicities ...

The top addiction researcher in the U.S. government is calling for the broad deregulation of methadone — a medication that can reduce dependency on opioids — in a major departure from how it is ...

Chronic cough affects some 80% of patients with idiopathic pulmonary fibrosis (IPF) and most patients consider it to be one of the most distressing IPF symptoms. In an early phase trial, the ...